The ACETAZ-HF trial: intravenous furosemide plus oral acetazolamide for rapid decongestion in acute HFrEF and sustained outpatient benefit

30 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Heart failure frontiers: from decongestion to advanced therapeutics Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology